Table of Contents Table of Contents
Previous Page  800 844 Next Page
Information
Show Menu
Previous Page 800 844 Next Page
Page Background

patient interrupted the therapy because of myalgia and

severe arthralgia. Bladder symptoms recurred 3 mo after

treatment discontinuation

[101]

.

According to the limited evidence available, hormonal

treatments are effective in temporarily suppressing,

but not curing, BE. Hence, if the decision is taken to

medically control the condition and avoid excisional

surgery, long-term treatment should be planned. In these

selected circumstances, estrogen-progestogen combina-

tions and progestogens should be chosen for their

efficacy, safety, and cost-effectiveness that allow pro-

longed periods of therapy, even up to physiologic

menopause

[81] .

Patients should be informed that the

disease may progress under medical treatment, so regular

follow-up is advisable.

3.3.2.

Surgical treatment of BE

Surgical treatment of BE nodules should be always

performed after an accurate diagnostic workup; this is

crucial to establish a differential diagnosis with malignant

lesions, to define the exact location of the nodule and its

relationship to the ureteral meatuses, and to clarify the

ureteral status. Two techniques have been proposed for

surgical treatment of BE: TUR surgery and partial cystec-

tomy (alone or in combination). The main objective of each

surgical procedure should be to entirely remove the bladder

lesion. Significant improvements in pain and urinary

symptoms have been observed after excision of the whole

bladder lesion

[102–106]

. Complete surgical excision

of nodules also minimizes the risk of recurrence

[103,105–109] . Table 1

summarizes the main advantages

Table 5 – Main characteristics and findings of studies investigating surgical treatment of bladder endometriosis

Study

Type Setting Patients,

n

(%)

Treatment

FU Symptom improvement,

Relapse,

n

(%)

Total

BE

type,

n

(mo)

n

(%)

Antonelli 2006

[108]

RS

SI

31 14 (45.2)

TUR: 2

PC: 9

LPS PC: 3

58

TUR: 0 (0)

PC: 9 (100)

LPS PC: 3 (100)

TUR: 2 (100)

PC: 0 (0)

LPS PC: 0 (0)

Perez-Utrilla 2009

[109]

RS

SI

12 5 (41.7)

TUR: 3

PC: 1

LPS PC: 1

65.6 TUR: NR

PC: NR

LPS PC: NR

TUR: 1 (33.3)

a

PC: 0 (0)

LPS PC: 0 (0)

Fuentes Pastor 2014

[110]

CS

SI

2 2 (100)

TUR: 2

11.5 TUR: 2 (100)

TUR: 0 (0)

Nezhat 1994

[102]

RS

SI

17 6 (35.3)

LPS PC: 6

NR

LPS PC: 6 (100)

LPS PC: 1 (16.7)

Chapron 1999

[103]

RS

SI

1650 8 (0.5)

LPS PC: 8

31.6 LPS PC: 8 (100)

LPS PC: 0 (0)

Seracchioli 2010

[104]

PS

SI

56 41 (73.2)

LPS PC: 41

55

LPS PC: NR

LPS PC: 0 (0)

Chapron 2010

[105]

PS

SI

627 75 (12.0)

LPS PC: 75

50.9 LPS PC: 75 (100)

LPS PC: 0 (0)

Soriano 2016

[106]

RS

SI

69 69 (100)

LPS PC: 69

36 LPS PC: 67 (97.1)

LPS PC: 2/69 (2.9)

Fedele 2005

[107]

RS

SI

47 47 (100)

PC: 29

LPS PC: 18

33.5 PC + LPS PC: 39 (83.0)

PC + LPS PC: 5 (10.6)

Chopin 2005

[111]

RS

SI

132 13 (9.8)

LPS PC: 13

39.6 LPS PC: 13 (100)

LPS PC: NR

Fleisch 2005

[112]

RS

SI

23 2 (8.6)

PC: 2

45.2 PC: NR

PC: NR

Rozsnyai 2011

[113]

RS

5I

30 15 (50)

LPS PC: 15

24.9 LPS PC: 15 (100)

LPS PC: 0 (0)

Kjer 2014

[114]

RS

SI

30 30 (100)

PC: 13

LPS PC: 17

44

PC: 13 (100)

LPS PC: 17 (100)

PC: 0 (0)

LPS PC: 0 (0)

Nezhat 1996

[115]

RS

SI

28 7 (25)

LPS PC: 7

24

LPS PC: 7 (100)

LPS PC: 0 (0)

Nezhat 2002

[116]

PS

SI

15 15 (100)

LPS PC: 15

NR

NR

NR

Seracchioli 2002

[117]

CR

SI

1 1 (100)

LPS PC: 1

NR

NR

NR

Salvatores 2007

[118]

RS

SI

21 21 (100)

LPS PC: 21

19

LPS PC: 21 (100)

NR

Granese 2008

[119]

RS

3I

8 8 (100)

LPS PC: 8

33.8 LPS PC: 5 (62.5)

LPS PC: 0 (0)

Walid 2009

[120]

CR

SI

1 1 (100)

LPS PC: 1

3

LPS PC: 1 (100)

NR

Kovoor 2010

[121]

RS

2I

169 21 (12.4)

LPS PC: 21

20

LPS PC: 18 (85.7)

NR

Lusuardi 2012

[122]

RS

2I

10 3 (30.0)

LPS PC: 3

26.5 LPS PC: 3 (100)

LPS PC: 0 (0)

Prager 2012

[123]

CR

SI

1 1 (100)

LPS PC: 1

18

LPS PC: 1 (100)

LPS PC: 0 (0)

Nezhat 2014

[124]

RS

3I

134 1 (0.7)

LPS PC: 1

NR

NR

NR

Chammas 2008

[125]

CR

SI

1 1 (100)

RA PC: 1

12

RA PC: 1 (100)

RA PC: 0 (0)

Liu 2008

[126]

CR

SI

1 1 (100)

RA PC: 1

2

b

RA PC: 1 (100)

RA PC: 0 (0)

Nezhat 2011

[127]

CS

SI

5 1 (20.0)

RA PC: 1

12

RA PC: 1 (100)

NR

Collinet 2014

[128]

RS

8I

164 23 (14.0)

RA PC: 23

9.7

NR

RA PC: 0 (0)

Siesto 2014

[129]

RS

SI

318 5 (1.6)

RA PC: 5

28

NR

RA PC: 0 (0)

Abo 2016

[130]

CS

SI

35 3 (8.5)

RA PC: 3

12

NR

RA PC: 0 (0)

Sener 2006

[132]

CR

SI

1 1 (100)

TUR + LPS PC: 1 3

TUR + LPS PC: 1 (100)

NR

Pang 2008

[133]

CR

SI

1 1 (100)

TUR + LPS PC: 1 14

TUR + LPS PC: 1 (100)

NR

Xiromeritis 2011

[134]

CR

SI

1 1 (100)

TUR + LPS PC: 1 NR

NR

NR

Litta 2012

[135]

PS

SI

12 12 (100)

TUR + LPS PC: 12 12

TUR + LPS PC: 11 (91.7)

NR

Cheng 2013

[136]

CR

SI

1 1 (100)

TUR + LPS PC: 1 6

TUR + LPS PC: 1 (100)

NR

Roman 2014

[137]

CR

SI

1 1 (100)

TUR + LPS PC: 1 NR

NR

NR

RS = retrospective study; PS = prospective study; CR = case report; CS = case series; SI = single institution; 2I, 3I, 5I, 8I = two, three, five, eight institutions;

FU = mean/median follow-up; LPS PC = laparoscopic partial cystectomy; NR = not reported; RA PC = robot-assisted PC; TUR = transurethral resection.

a

The same patient experienced two relapses after two TUR procedures.

b

At this follow-up the patient became pregnant.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 7 9 0 – 8 0 7

800